Literature DB >> 3077420

[A totally implantable permanent central venous access, long-term experience with subcutaneous infusion chambers].

M Lorenz1, C Hottenrott, R M Seufert, A Encke.   

Abstract

Subcutaneously implanted infusion chambers represent a new method of central venous access. In 57 evaluable out of 70 patients, four different models of infusion chambers with an accumulative observation time of 57 years were implanted. In 72% of the patients, up to 12 cycles of polychemotherapy were administered. Parenteral nutrition and blood drawing were also performed. After 4,970 punctions of the system and 12.2 years of use 46 complications in 38 patients were observed, however, most were minor ones, such as temporary occlusions (12) and extravasations (14). Septum luxation (1), septum perforation (1), catheter fracture (1) and catheter migration (2) as well as 7 cases of septicemia or port-pocket-infection required explanation. Infusion chambers seem to be particularly suitable for intermittent and long-term chemotherapy and emergency bolus injections with a significant advantage (10 complications per one thousand days of use) compared to externally placed venous catheters. However, follow-up and care must be performed by a skilled team.

Entities:  

Mesh:

Year:  1988        PMID: 3077420     DOI: 10.1007/bf01276546

Source DB:  PubMed          Journal:  Langenbecks Arch Chir        ISSN: 0023-8236


  26 in total

1.  Drug extravasation as a complication of venous access ports.

Authors:  W P Reed; K A Newman; M M Applefeld; F J Sutton
Journal:  Ann Intern Med       Date:  1985-06       Impact factor: 25.391

2.  Thromboembolic complications associated with L-asparaginase therapy. Etiologic role of low antithrombin III and plasminogen levels and therapeutic correction by fresh frozen plasma.

Authors:  O Kucuk; H C Kwaan; W Gunnar; R M Vazquez
Journal:  Cancer       Date:  1985-02-15       Impact factor: 6.860

3.  Catheter fractures in implantable vascular access systems.

Authors:  G S May
Journal:  Lancet       Date:  1986-09-20       Impact factor: 79.321

4.  Percutaneous placement of two single-lumen Silastic catheters for long-term venous access. Lessons learned with experience in over 200 patients.

Authors:  C Carroll; M G Sarr; J R Stewart
Journal:  Cancer       Date:  1985-06-01       Impact factor: 6.860

5.  Long-term intravenous therapy with peripherally inserted silicone elastomer central venous catheters in patients with malignant diseases.

Authors:  J Bottino; K B McCredie; D H Groschel; M Lawson
Journal:  Cancer       Date:  1979-05       Impact factor: 6.860

6.  Two methods for improved venous access in acute leukemia patients.

Authors:  J C Wade; K A Newman; S C Schimpff; D A VanEcho; R A Gelber; W P Reed; P H Wiernik
Journal:  JAMA       Date:  1981-07-10       Impact factor: 56.272

7.  Indwelling venous access catheters in patients with acute leukemia.

Authors:  J J Reilly; D L Steed; P S Ritter
Journal:  Cancer       Date:  1984-01-15       Impact factor: 6.860

8.  Central venous access with occlusive superior central venous thrombosis.

Authors:  M H Torosian; S Meranze; G McLean; J L Mullen
Journal:  Ann Surg       Date:  1986-01       Impact factor: 12.969

9.  [Continuous intravenous or intra-arterial administration via a subcutaneous implantable infusion chamber. Preliminary clinical experiences with particular reference to intra-arterial chemotherapy].

Authors:  M Lorenz; C Hottenrott; R M Seufert; M Kirkowa-Reimann; A Encke
Journal:  Dtsch Med Wochenschr       Date:  1986-05-16       Impact factor: 0.628

10.  Results from use of 826 vascular access devices in cancer patients.

Authors:  J H Raaf
Journal:  Cancer       Date:  1985-03-15       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.